Göktürk Dere

Göktürk Dere

Auto-generated profile, based on publicly available information

Göktürk Dere

Department of Dermatology Ordu State Hospital Ordu Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
GDGöktürk Dere
Göktürk Dere
MGMustafa Gündoğdu
Mustafa Gündoğdu

8 March 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
MGMustafa Gundogdu
Mustafa Gundogdu
GDGokturk Dere
Gokturk Dere
Aim: To investigate whether acne treatment agent systemic isotretinoin causes susceptibility to COVID‐19 disease.Material and method: Patients admitted to a single center due to acne between March 2020 and December 2020 were included. A retrospective analysis was conducted on the medical records of acne patients receiving systemic isotretinoin or topical treatments. The patients with PCR‐confirmed SARS‐CoV‐2 infection were recorded.Results: 302 patients who used isotretinoin and 329 patients who used topical treatment were included in the study. No statistically significant difference was found between the groups in terms of age (p = 0.151). It was found that of the 302 patients who used isotretinoin, 33 had PCR test for SARS‐CoV‐2 and two of these had PCR positivity, while of the 329 patients who received topical treatment, 45 had PCR test and five of these had PCR positivity. No statistically significant difference was found between the groups in terms of having SARS‐CoV‐2 positivity with PCR (p = 0.692).Conclusion: Susceptibility to COVID‐19 disease was not observed in patients using systemic isotretinoin.

8 June 2021
Verified
Preprint
Open access
PDF file
GDGöktürk Dere
Göktürk Dere
MOMurat Ozturk
Murat Ozturk
Aim: Vitamin D affects the secretion of antimicrobial peptides associated with toll-like receptor (TLR), which have antiviral effects. It has been suggested that vitamin D may affect the susceptibility of the host to varicella zoster virus (VZV) and the clinical course of zona zoster. Materials and Methods: In this study, 101 patients who were diagnosed with zona zoster at the dermatology outpatient clinic and had a vitamin D result at the time of diagnosis and a control group of 100 people were included. Results were analyzed statistically. Results: The 25-OH vitamin D levels of the patients ranged from 2.37 to 32.98 µg / L and the mean value was 14.25 ± 7.20 µg / L. In the control group, 25-OH vitamin D levels ranged between 10.3 and 44.25 µg / L, and the mean value was 24.9 ± 6.24 µg / L. 25-OH vitamin D levels in the patient group were significantly lower than the levels in the control group. (p <0.001) Conclusion: This study revealed that 25-OH vitamin D levels were significantly lower in patients with zona zoster compared to the control group. 25-OH vitamin D deficiency may increase the risk of VZV reactivation, and vitamin D supplementation in patients with vitamin D deficiency in zona zoster may help the mild course of the disease.